About ConSynSys Technologies

Meet the Experts in revolutionizing Biopharma Manufacturing

How we got started

Founded in January 2021, ConSynSys Technologies was born out of a vision to revolutionize process control in the biopharmaceutical industry. Recognizing the need for more efficient, secure, and scalable solutions, we set out to develop ProCaaSo®—the first cloud-native process control platform designed specifically for biopharma manufacturing. Our mission from day one has been to streamline operations, reduce costs, and ultimately help bring life-saving drugs to market faster. With a team of experts in automation, software development, and biopharmaceutical processes, we’ve grown from an ambitious idea to a trusted partner in the industry, helping clients modernize and optimize their operations.

About ConSynSys

Beyond Biopharma: Leading the Charge for Industry 4.0

While we began our journey in biopharma, our vision extends beyond a single industry. ConSynSys Technologies is at the forefront of Industry 4.0, pioneering automation solutions that are revolutionizing how industries operate. By leveraging cloud-native technologies and cutting-edge automation tools, we are driving the future of manufacturing across various sectors, enabling businesses to embrace smarter, more efficient processes. From predictive maintenance to real-time data-driven decisions, we’re helping industries redefine their potential in an increasingly digital world.

Our Offices

Our company operates from two strategic locations: one office is based in Nevada, USA, and the other in Estonia, Europe. This global presence enables us to serve our clients effectively across different regions.

Map

Our Team

Executive Team

Dean Richards

Greg Benoy

Greg Benoy

Mia Gagne

Mia Gagne

Michael Gagne

Michael Gagne

Blake Warner

Blake Warner

ProCaaSo® Platform Team

Mihkel Väli

Endrit Toplica

Lauri Sild

Mered Migel Kalinin

Travis Smith

Travis Smith

Bohdan Keller

Artur Hearhizau

Pacific Regmi

Automation Team

Brandon Smith

Brandon Smith

Michael Dorado

Michael Dorado

Krystianne Vega

Krystianne Vega

Advisory Board

Mark Weatherington

Mark Weatherington

Kevin Prahm

Kevin Prahm